Clinical trial · Observational
Social Determinants of Health in Glioblastoma Population
Defining Personal and Communal Aspects of Social Determinants of Health in Glioblastoma Population
NCT03900689CI-TRIAL-00120244completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall aim of this study is to prospectively characterize social health disparities in a cross-sectional cohort of glioma patients with attention to exploring and thematically categorizing the patient-specific and community-level factors. This will be conducted in two parts.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Astrocytoma | Astrocytoma | CURATED_BROADER | 0.80 |
| Ependymoma | Ependymoma | ONTOLOGY_EXACT | 0.90 |
| Ganglioglioma | Ganglioglioma | ONTOLOGY_EXACT | 0.90 |
| Glioma | Glioma | ONTOLOGY_EXACT | 0.98 |
| Oligodendroglioma | Oligodendroglioma | CURATED_BROADER | 0.80 |
| Pleomorphic Xanthoastrocytoma | Pleomorphic Xanthoastrocytoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Part 1 Survey Group | Other | — | UNRESOLVED |
| Part 2 Focus Group | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Health Services Research - Part 1 Survey
- description
- Participants will be asked to complete a series of surveys. This will be preferentially completed on the same day of the visit but may be completed at a subsequent visit, over the telephone or taken home and sent back to the clinic.
- interventionNames
- Other: Part 1 Survey Group
- label
- Health Services Research - Part 2 - Focus Group
- description
- Patients identified in Part 1 will be offered participation in the focus groups in Part 2. All patients enrolled in Part 1 will be considered for participation in Part 2. Approximately 30 total patients will be invited to participate. Patients who agree to be contacted will receive a telephone call or contacted in clinic and invited to participate in the Part 2 focus group.
- interventionNames
- Other: Part 2 Focus Group
Primary outcomes (3)
- measure
- PRAPARE Instrument Questionnaire
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Part 1: * Adults who are 18 years or older * Have a histologically confirmed glioma of any grade (WHO Grade 2-4: astrocytoma, oligodendroglioma, ependymoma, ganglioglioma, pleomorphic xanthroastrocytoma) * Currently receiving primary oncologic care at Wake Forest Baptist Comprehensive Cancer Center * Have the ability to speak and read either English or Spanish. * Ability to provide informed consent Part 2: * Participants who participated in Part 1 and express willingness to be contacted about Part 2 * Ability to provide informed consent * Ability to speak and understand English Inclusion of Women and Minorities (for Part 1 and Part 2) • Women of all races and ethnicity who meet the above-described eligibility criteria are eligible for this trial. Exclusion Criteria: • Patients who are unable to read or complete the required study-related forms. Patients who are unable to read but can be assisted by a proxy or family member will be included.
References
Publications (0)
Data not yet available
No reference posted for this study.